112949 ⎘
Oligonucleotides characterized by their use Screening for pharmacological compounds
Tumor suppressor killin
#1502Method of diagnosing and treating interstitial cystitis
#1503Methods and compositions for treating and diagnosing diseases
#1504Gefitnib Sensitivity-Related Gene Expression and Products and Methods Related Thereto
#1505Methods of treating lung cancer using inhibitors anaplastic lymphoma kinase
#1506CHK2 polymorphism as a cancer marker
#1507BCR-ABL1 splice variants and uses thereof
#1508Further use of protein kinase N beta
#1509Modulation of Dynein in Skin
#1510Screening methods for cognitive enhancers
#1511TREATMENT OF NEURODEGENERATION AND NEUROINFLAMMATION
#1512Method of treating skin with microRNA modulators
#1513Uses of CD116 Expression Level
#1514METHODS AND COMPOSITIONS FOR ASSESSMENT OF PULMONARY FUNCTION AND DISORDERS
#1515MAMMALIAN OOCYTE DEVELOPMENT COMPETENCY GRANULOSA MARKERS AND USES THEREOF
#1516METHODS USING AXL AS A BIOMARKER OF EPITHELIAL-TO-MESENCHYMAL TRANSITION
#1517Identification of inhibitors of a bacterial stress response
#1518Method for prediction of therapeutic effect of chemotherapy employing expression level of dihydropyrimidine dehydrogenase gene as measure
#1519Treatment of insulin gene (INS) related diseases by inhibition of natural antisense transcript to an insulin gene (INS)
#1520Methods for modulating the expression and aggregation of CAG-expanded gene product in cells and methods for identifying agents useful for doing the same
#1521Effects of Inhibitors of FGFR3 on Gene Transcription
#1522GLUCOCORTICOID RECEPTOR ALLELES AND USES THEREOF
#1523Markers for diagnosis of pulmonary inflammation and methods related thereto
#1524METHODS OF PREDICTING THE RISK OF RECURRENCE OF CANCER
#1525MODULATION OF TRANSTHYRETIN EXPRESSION
#1526Method of screening a substance for improving insulin resistance
#1527Genetic Variants in the TCF7L2 Gene as Diagnostic Markers for Risk of Type 2 Diabetes Mellitus
#1528Diagnosis and treatment of adrenocortical tumors using human microRNA-483
#1529DIAGNOSTIC TRANSCRIPTOMIC BIOMARKERS IN INFLAMMATORY CARDIOMYOPATHIES
#1530Inhibitors of heat shock RNA
#1531HEPATITIS B VIRUS MUTATION STRAIN WITH RESISTANCE TO ADEFOVIR DIPIVOXIL AND THE USES THEREOF
#1532NOVEL COMPOSITIONS AND METHODS FOR THE IDENTIFICATION, ASSESSMENT, PREVENTION AND THERAPY OF HUMAN CANCERS
#1533Molecular targets for ALS and related disorders
#1534PROSTATE SPECIFIC TRANSCRIPTS AND THE USE THEREOF FOR PROSTATE CANCER THERAPEUTICS AND DIAGNOSTICS
#1535ANTIVIRAL TREATMENT OF LYMPHOMA AND CANCER
#1536Treatment of ‘C terminus of HSP70-interacting protein’ (CHIP)related diseases by inhibition of natural antisense transcript to CHIP
#1537METHODS FOR DETERMINING SENSITIVITY TO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2 MODULATORS
#1538Fibrosis susceptibility gene and uses thereof
#1539Method for identifying interventions that control the translational activity of ribosomal proteins in differential mRNA expression
#1540Treatment of Adiponectin related diseases by inhibition of natural antisense transcript to an Adiponectin
#1541BIOMARKERS FOR THE PROGNOSIS AND HIGH-GRADE GLIOMA CLINICAL OUTCOME
#1542Pancreatic cancer targets and uses thereof
#1543Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors
#1544BRM Expression and Related Diagnostics
#1545Genetic Variants Predictive of Cancer Risk in Humans
#1546Isolation and growth of stem cells from hemangiomas
#1547Modulation of STAT 6 expression
#1548METHODS FOR TREATMENT OF BACTERIAL INFECTIONS
#1549Assay methods for the determination of FKBPL expression level in the context of breast cancer
#1550Methods for Screening for Antibiotic Compounds
#1551MARKER FOR PROGNOSIS OF LIVER CANCER
#1552METHOD FOR TESTING A SUBJECT THOUGHT TO BE PREDISPOSED TO HAVING METASTATIC CANCER USING DELTA133P53BETA
#1553METHODS FOR DIAGNOSIS AND PROGNOSIS OF CANCER
#1554METHODS AND COMPOSITIONS RELATED TO SYNERGISTIC RESPONSES TO ONCOGENIC MUTATIONS
#1555Methods of identifying infectious disease and assays for identifying infectious disease
#1556MODULATION OF THE TGF- ß AND PI3K/AKT PATHWAYS IN THE DIAGNOSIS AND TREATMENT OF SQUAMOUS CELL CARCINOMA
#1557CHROMOSOME 3p21.3 GENES ARE TUMOR SUPPRESSORS
#1558COMPOSITIONS AND METHODS FOR TREATING SKIN DISORDERS
#1559ZNF217 a new prognostic and predictive biomarker of recurrent invasive and metastatic phenotypes in breast cancer
#1560Use of Vgll3 activity modulator for the modulation of adipogenesis
#1561Biomarker and Treatment for Cancer
#1562PROBE SET FOR IDENTIFICATION OF NUCLEOTIDE MUTATION, AND METHOD FOR IDENTIFICATION OF NUCLEOTIDE MUTATION
#1563Protein tyrosine phosphatase mutations in cancers
#1564Genetic alterations on chromosome 12 and methods of use thereof for the diagnosis and treatment of type 1 diabetes
#1565BIOMARKERS AND METHODS FOR DETERMINING EFFICACY OF ANTI-EGFR ANTIBODIES IN CANCER THERAPY
#1566MicroRNAs and uses thereof
#1567NEURODEGENERATIVE DISEASE DIAGNOSTIC COMPOSITIONS AND METHODS OF USE
#1568ASSAY FOR DETERMINING EPIGENETIC PROFILES OF MARKERS OF FRAGILE X ALLELES
#1569Methods and compositions for detecting gastrointestinal and other cancers
#1570IN VITRO METHODS FOR DETERMINING AN INTRACELLULAR FREE MAGNESIUM DEFICIENCY OF INDIVIDUALS BY DETERMINING THE EXPRESSION RATE OF A CELLULAR MG TRANSPORTER GENE
#1571miRNAS AS THERAPEUTIC TARGETS IN CANCER
#1572DIAGNOSIS AND TREATMENT OF CELL PROLIFERATION AND DIFFERENTIATION DISORDERS BASED ON THE FMN2 GENE
#1573GENETIC POLYMORPHISMS ASSOCIATED WITH PSORIASIS, METHODS OF DETECTION AND USES THEREOF
#1574MOLECULAR PREDICTORS OF FUNGAL INFECTION
#1575COMPOSITIONS AND METHODS FOR PREDICTING HCV SUSCEPTIBILITY TO ANTIVIRAL AGENTS
#1576Method of diagnosing poor survival prognosis colon cancer using miR-29a
#1577Method of diagnosing poor survival prognosis colon cancer using miR-103-2
#1578TARGETS IN BREAST CANCER FOR PROGNOSIS OR THERAPY
#1579Chromosome 3p21.3 genes are tumor suppressors
#1580Modulation of kit signaling and hematopoietic cell development by IL-4 receptor modulation
#1581Method for the treatment of acquired lymphedema
#1582Lung cancer markers, and uses thereof
#1583GENES ASSOCIATED WITH PROGRESSION AND RESPONSE IN CHRONIC MYELOID LEUKEMIA AND USES THEREOF
#1584Therapy with enterotoxin to treat ovarian and uterine cancer
#1585Methods for predicting and treating tumors resistant to drug, immunotherapy and radiation
#1586METHODS AND COMPOSITIONS FOR TREATING CANCER
#1587TREATMENT OF PANCREATIC CANCER USING A DR5 AGONIST IN COMBINATION WITH GEMCITABINE
#1588Test agent for visceral obesity and use thereof
#1589Detection and treatment of schizophrenia
#1590METHOD OF PREDICTING CHEMOTHERAPY EFFECTIVENESS IN COLON ADENOCARCINOMA PATIENTS, USING MIR-21
#1591Method of diagnosing poor survival prognosis colon cancer using miR-106a
#1592Markers of renal transplant rejection and renal damage
#1593METHOD FOR THE DIAGNOSIS AND TREATMENT OF CARDIOVASCULAR DISEASES
#1594Nucleic Acids, Polypeptides, Compositions, and Methods for Modulating Apoptosis
#1595GENETIC POLYMORPHISMS ASSOCIATED WITH LIVER FIBROSIS, METHODS OF DETECTION AND USES THEREOF
#1596Method and kit for evaluation of predisposition to development of obesity, anti-obesity agent and method for screening thereof, non-human animal, adipose tissue, adipocyte, method for production of transgenic mouse, antigen, and antibody
#1597Method of predicting a predisposition to QT prolongation
#1598Method of diagnosing poor survival prognosis colon cancer using miR-10a
#1599Method of diagnosing poor survival prognosis colon cancer using miR-203
#1600Method of diagnosing poor survival prognosis colon cancer using miR-16b
#1601Method of diagnosing poor survival prognosis colon cancer using let-7g
#1602Method of diagnosing poor survival prognosis colon cancer using miR-181b
#1603Method of predicting a predisposition to QT prolongation
#1604Cancer-associated antigen
#1605MOLECULAR MARKERS FOR CANCER PROGNOSIS
#1606METHODS AND COMPOSITIONS RELATED TO THE REGULATION OF GOBLET CELL DIFFERENTIATION, MUCUS PRODUCTION AND MUCUS SECRETION
#1607METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF CANCER
#1608METHODS OF SCREENING FOR RISK OF PROLIFERATIVE DISEASE AND METHODS FOR THE TREATMENT OF PROLIFERATIVE DISEASE
#1609TUMOR MARKERS AND METHODS OF USE THEREOF
#1610FUS/TLS-based compounds and methods for diagnosis, treatment and prevention of amyotrophic lateral sclerosis and related motor neuron diseases
#1611Mutations in the LNK gene in patients with myeloproliferative neoplasms and other hematolymphoid malignancies
#1612ADRB2 cancer markers
#1613HP1ALPHA AS A PROGNOSTIC MARKER IN HUMAN CANCER
#1614JARID1B FOR TARGET GENE OF CANCER THERAPY AND DIAGNOSIS
#1615gene and its involvement in Hutchinson-Gilford Progeria Syndrome (HGPS) and arteriosclerosis
#1616Single Nucleotide Polymorphism Within An Intronic P53 Binding Motif of the Prkag2 Gene
#1617SMALL MOLECULE IMMUNOMODULATORS FOR ALZHEIMER'S DISEASE
#1618GLUCOCORTICOID RECEPTOR ALLELES AND USES THEREOF
#1619PROTEIN TARGETS IN DISEASE
#1620Methods and Reagents for Treatment and Diagnosis of Vascular Disorders and Age-Related Macular Degeneration
#1621TISSUE-SPECIFIC AGING BIOMARKERS
#1622Methods of Detecting Diseases or Conditions Using Phagocytic Cells
#1623Compositions and methods for diagnosing prostate cancer based on detection of SLC45A3-ELK4 fusion transcript
#1624Biomarkers for Graft Rejection
#1625Genetic polymorphisms associated with venous thrombosis, methods of detection and uses thereof
#1626Genes associated with posttraumatic-stress disorder (PTSD)
#1627PARP1 TARGETED THERAPY
#1628PROGNOSIS OF BREAST CANCER PATIENTS BY MONITORING THE EXPRESSION OF TWO GENES
#1629Use of micro-RNA as a biomarker of immunomodulatory drug activity
#1630MICRORNA AS A BIOMARKER OF PANCREATIC ISLET BETA-CELL ENGAGEMENT
#1631GENES AND POLYPEPTIDES RELATING TO HUMAN PANCREATIC CANCERS
#1632COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING INFLAMMATORY BOWEL DISEASE AND COLON CANCER
#1633MicroRNAs in Never-Smokers and Related Materials and Methods
#1634METHOD AND COMPOSITIONS FOR CANCER PROGNOSIS
#1635BREAST CANCER RELATED GENE RQCD1
#1636Compositions and methods for diagnosis and prognosis of cancer and progression, and for screening anti-cancer agents
#1637Method of diagnosing esophageal cancer
#1638Hypoxia-Inducible Protein 2 (HIG2), a Diagnostic Marker for Clear Cell Renal Cell Carcinoma
#1639Signature for the diagnosis of cancer aggressiveness and genetic instability
#1640RADIATION THERAPY BIOMARKERS
#1641MUTATIONS IN THE BCR-ABL TYROSINE KINASE ASSOCIATED WITH RESISTANCE TO STI-571
#1642Bacterial DNA as Markers of Cardiovascular and/or Metabolic Disease
#1643METHODS OF PREDICTING CLINICAL COURSE AND TREATING MULTIPLE SCLEROSIS
#1644POT1 alternative splicing variants
#1645RECURRENT GENE FUSIONS IN CANCER
#1646Method and kit for diagnosing autism using gene expression profiling
#1647METHOD FOR THERAPY PREDICTION IN TUMORS HAVING IRREGULARITIES IN THE EXPRESSION OF AT LEAST ONE VEGF LIGAND AND/OR AT LEAST ONE ERBB-RECEPTOR
#1648Enigma-Mdm2 interaction and uses thereof
#1649METHODS AND MATERIALS FOR ASSESSING LOSS OF HETEROZYGOSITY
#1650METHOD OF DIAGNOSING BLADDER CANCER
#1651Alternative splicing variant of OATP1B3 mRNA
#1652GENETIC POLYMORPHISMS ASSOCIATED WITH PSORIASIS, METHODS OF DETECTION AND USES THEREOF
#1653TBC1D7 AS TUMOR MARKER AND THERAPEUTIC TARGET FOR CANCER
#1654METHODS AND COMPOSITIONS FOR IDENTIFICATION, ASSESSMENT AND TREATMENT OF CANCERS ASSOCIATED WITH HEDGEHOG SIGNALING
#1655Targeting of podoplanin with lectin for use in the prevention and treatment of cancer
#1656Modulation of ABCG2-mediated urate transport to treat hyperuricemia and gout
#1657METHODS FOR DIAGNOSIS AND PROGNOSIS OF PULMONARY HYPERTENSION
#1658Methods for identifying fragile histidine triad (FHIT) interaction and uses thereof
#1659METHOD OF DIAGNOSING BREAST CANCER
#1660Gene Expression Profiling for Predicting the Survivability of Prostate Cancer Subjects
#1661Renal cell carcinoma biomarkers
#1662Treatment of nuclear factor (erythroid-derived 2)-like 2 (NRF2) related diseases by inhibition of natural antisense transcript to NRF2
#1663Diagnostic Marker for Migraine and Use Thereof
#1664METHODS FOR APCDD1 MEDIATED REGULATION OF HAIR GROWTH AND PIGMENTATION AND MUTANTS THEREOF
#1665Treatment of brain derived neurotrophic factor (BDNF) related diseases by inhibition of natural antisense transcript to BDNF
#1666Diagnosis, prognosis and identification of potential therapeutic targets of multiple myeloma based on gene expression profiling
#1667SNPs of apolipoprotein B and modulation of their expression
#1668Susceptibility to HSP90-Inhibitors
#1669Methods and means for typing a sample comprising colorectal cancer cells
#1670ECT2 ONCOGENE AS A THERAPEUTIC TARGET AND PROGNOSTIC INDICATOR FOR LUNG AND ESOPHAGEAL CANCER
#1671PUMA, a pro-apoptotic gene, as a novel molecular biomarker for TNFα-induced human islet damage
#1672DRUG IDENTIFICATION PROTOCOL FOR TYPE 2 DIABETES BASED ON GENE EXPRESSION SIGNATURES
#1673CANCER RELATED GENE, LGN/GPSM2
#1674Methods employing non-coding RNA expression assays
#1675COMPOSITION FOR DIAGNOSING PARKINSON'S DISEASE CONTAINING ADIPOSE TISSUE-DERIVED MESENCHYMAL STROMAL CELL
#1676WISP polypeptides and nucleic acids encoding same
#1677Antibodies that bind polypeptides involved in the process of bone remodeling
#1678Genetic Variants Underlying Human Cognition and Methods of Use Thereof as Diagnostic and Therapeutic Targets
#1679POLYPEPTIDES AND POLYNUCLEOTIDES, AND USES THEREOF AS A DRUG TARGET FOR PRODUCING DRUGS AND BIOLOGICS
#1680METHODS AND COMPOSITIONS FOR DETECTING CANINE DILATED CARDIOMYOPATHY (DCM)
#1681Gene Expression Profiling for Identification, Monitoring, and Treatment of Osteoarthritis
#1682METHODS OF REDUCING MICROBIAL RESISTANCE TO DRUGS
#1683METHODS AND COMPOSITIONS FOR ASSESSING AND TREATING METASTASIS, METASTATIC CANCER, AND POTENTIAL FOR METASTASIS
#1684Biomarkers for human papilloma virus-associated cancers
#1685NECTIN-4 FOR TARGET GENES OF CANCER THERAPY AND DIAGNOSIS
#1686Methods for characterizing agonists and partial agonists of target molecules
#1687Compositions and Methods for Identifying Autism Spectrum Disorders
#1688EGFR INHIBITOR THERAPY RESPONSIVENESS
#1689Genetic variants for breast cancer risk assessment
#1690Methods for diagnosing or treating prostate cancer
#1691Compositions and methods of identifying tumor specific neoantigens
#1692Treatment of chronic pelvic pain syndrome
#1693GENETIC POLYMORPHISMS ASSOCIATED WITH RHEUMATOID ARTHRITIS, METHODS OF DETECTION AND USES THEREOF
#1694Animal Model for Osteoarthritis and Intervertebral Disc Disease
#1695METHODS OF CHARACTERIZING BREAST CANCER AND IDENTIFYING TREATMENTS FOR SAME
#1696TARGETS, METHODS, AND REAGENTS FOR DIAGNOSIS AND TREATMENT OF SCHIZOPHRENIA
#1697Compositions for treating arthritis comprising HG1023575 polypeptide
#1698Genetic Variants Useful for Risk Assessment of Thyroid Cancer
#1699Methods for identifying kremen polypeptide binding partners
#1700Genetic Alterations on Chromosome 16 and Methods of Use Thereof for the Diagnosis and Treatment of Type 1 Diabetes
#1701Methods of diagnosing and treating fibrosis
#1702Novel, Prostate-Specific Gene for Diagnosis, Prognosis and Management of Prostate Cancer
#1703Rationale, methods, and assays for identifying human and non-human primate taste specific genes and use thereof in taste modulator and therapeutic screening assays
#1704Methods for treatment of cardiovascular disease
#1705Ets-2 Biomarkers for Fibrotic Diseases and Uses Thereof
#1706METHODS FOR TREATING NEOPLASIA AND FOR IDENTIFYING COMPOSITIONS USEFUL IN SUCH THERAPY
#1707MicroRNA-Based Methods and Compositions for the Diagnosis, Prognosis and Treatment of Ovarian Cancer Using a Real-Time PCR Platform
#1708METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF EPITHELIAL CANCERS
#1709Proteoglycan splice variants as therapeutics and diagnostics for amyloid diseases
#1710SOX MODULATORS IN THE TREATMENT OF ALOPECIA
#1711EGFR mutations
#1712METHODS AND MECHANISMS INVOLVING HYPERPIGMENTATION PARTICULARLY FOR AFRICAN AMERICAN SKIN
#1713Genetic Alterations Associated with Schizophrenia and Methods of Use Thereof for the Diagnosis and Treatment of the Same
#1714Method for predicting clinical outcome of patients with non-small cell lung carcinoma
#1715Genetic Variants as Markers for Use in Urinary Bladder Cancer Risk Assessment, Diagnosis, Prognosis and Treatment
#1716Clinical Method for Individualized Epithelial Cancer Screening Involving ERCC5 and IGF2R Genetic Testing and Gene-Environment Interactions
#1717METHODS AND COMPOSITIONS FOR PREDICTING DEVELOPMENT OF ATOPIC DISEASES
#1718PCTP MODULATORS IN THE TREATMENT OF ACNE, OF SEBORRHOEIC DERMATITIS OR OF HYPERSEBORRHOEA
#1719Signatures and PCDeterminants Associated with Prostate Cancer and Methods of Use Thereof
#1720C12ORF48 AS A TARGET GENE FOR CANCER THERAPY AND DIAGNOSIS
#1721GOS2 MODULATORS IN THE TREATMENT OF ACNE, OF SEBORRHOEIC DERMATITIS OR OF HYPERSEBORRHOEA
#1722Interferon Response in Clinical Samples (IRIS)
#1723METHOD FOR THE PROGNOSIS AND DIAGNOSIS OF TYPE II DIABETES IN CRITICAL PERSONS
#1724Susceptibility variants for peripheral arterial disease and abdominal aortic aneurysm
#1725Transcriptional Profiling and Biomarker-Based Methods for Identifying and Evaluating Agents for Antioxidant Efficacy in Cosmetic Skin Care Formulations
#1726Compositions, Kits, and Methods for the Diagnosis, Prognosis, and Monitoring of Cancer Using GOLPH3
#1727SYNGR4 FOR TARGET GENES OF CANCER THERAPY AND DIAGNOSIS
#1728MODULATORS OF ISOVALERYL-COENZYME A DEHYDROGENASE IN THE TREATMENT OF ACNE, OF SEBORRHOEIC DERMATITIS OR OF HYPERSEBORRHOEA
#1729MODULATORS OF MONOGLYCERIDE LIPASE IN THE TREATMENT OF ACNE, OF SEBORRHOEIC DERMATITIS OR OF HYPERSEBORRHOEA
#1730Use of ERBB4 as a prognostic and therapeutic marker for melanoma
#1731Molecular marker for cancer stem cell
#1732Breast endothelial cell expression patterns
#1733Mammalian tumor susceptibility genes and their uses
#1734METHODS AND COMPOSITIONS FOR TREATING NEUROLOGICAL DISEASE
#1735Use of TRIM72 as a target for muscle and heart enhancer
#1736Methods and Compositions for Promoting Bone Growth
#1737PANCREATIC CANCER RELATED GENE TTLL4
#1738Method for screening cancer therapeutic agent using galectin-3, GSK-3β, and fascin-1
#1739USE OF MICRORNA SIGNATURES FOR ASSESSING RISK LEVELS OF NEUROBLASTOMA PATIENTS
#1740Genetic Alterations Associated with Type I Diabetes and Methods of Use Thereof for Diagnosis and Treatment
#1741Treatment of erythropoietin (EPO) related diseases by inhibition of natural antisense transcript to EPO
#1742Treatment of vascular endothelial growth factor (VEGF) related diseases by inhibition of natural antisense transcript to VEGF
#1743BIOMARKERS FOR DRUG-INDUCED ELONGATED QT INTERVAL AND TORSADES DE POINTES
#1744ZAP-70 expression as a marker for chronic lymphocytic leukemia / small lymphocytic lymphoma (CLL/SLL)
#1745MATERIALS AND METHODS FOR DETERMINING DIAGNOSIS AND PROGNOSIS OF PROSTATE CANCER
#1746NOVEL MARKERS FOR DIAGNOSING BRAIN DISEASE CAUSED BY BRAIN INJURY AND USE THEREOF
#1747LGR5 MODULATORS IN THE TREATMENT OF ALOPECIA
#1748METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING A COLORECTAL ADENOCARCINOMA
#1749Genetic Alterations on Chromosomes 21q, 6q and 15q and Methods of Use Thereof for the Diagnosis and Treatment of Type I Diabetes
#1750NOVEL NARC SC1, NARC 10A, NARC 1, NARC 12, NARC 13, NARC17, NARC 25, NARC 3, NARC 4, NARC 7, NARC 8, NARC 11, NARC 14A, NARC 15, NARC 16, NARC 19, NARC 20, NARC 26, NARC 27, NARC 28, NARC 30, NARC 5, NARC 6, NARC 9, NARC 10C, NARC 8B, NARC 9, NARC2A, NARC 16B, NARC 1C, NARC 1A, AND NARC 25 MOLECULES AND USES THEREFOR
#1751GENE EXPRESSION CLASSIFIERS FOR RELAPSE FREE SURVIVAL AND MINIMAL RESIDUAL DISEASE IMPROVE RISK CLASSIFICATION AND OUTCOME PREDICTION IN PEDIATRIC B-PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA
#1752Genetic Variants Useful for Risk Assessment of Thyroid Cancer
#1753Methods for stratifying and annotating cancer drug treatment options
#1754SCREENING METHODS FOR IDENTIFYING SPECIFIC STAPHYLOCOCCUS AUREUS INHIBITORS
#1755COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING CANCER AND NEURODEGENERATIVE DISEASES RLATED TO BECLIN-1
#1756SYNGAP1 DYSFUNCTIONS AND USES THEREOF IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS FOR MENTAL RETARDATION
#1757EGFR mutations
#1758COMPOSITIONS AND METHODS FOR MODULATING AN IMMUNE RESPONSE
#1759Teneurin and cancer
#1760TUMOR ANGIOGENESIS ASSOCIATED GENES AND A METHOD FOR THEIR IDENTIFICATION
#1761Genetic alterations in isocitrate dehydrogenase and other genes in malignant glioma
#1762USE OF P2X7 PATHWAY FOR ASSESSING THE SENSITIVITY OF A SUBJECT TO A CANCER TREATMENT
#1763Micro RNA (MiRNA) and neurofibromatosis type 1: a role in diagnosis and therapy
#1764FZD2 Molulators in the Treatment of Alopecia
#1765Gene expression signature of genomic instability in breast cancer
#1766Biomarkers for subtypes of cervical cancer
#1767METHOD FOR DIAGNOSING NON-SMALL CELL LUNG CANCER
#1768MicroRNAs and Uses Thereof
#1769METHODS FOR DIAGNOSING CANCER AND DETERMINING THE OVERALL SURVIVAL AND DISEASE-FREE SURVIVAL OF CANCER PATIENTS
#1770Method of prognosing and diagnosing hereditary spastic paraplegia, mutant nucleic acid molecules and polypeptides
#1771GENE ASSOCIATED WITH LIVER CANCER, AND METHOD FOR DETERMINATION OF THE RISK OF ACQUIRING LIVER CANCER
#1772BIOMARKERS OF OSTEOARTHRITIS
#1773Methods and compositions for detecting colon cancers
#1774Methods and compositions for risk prediction, diagnosis, prognosis, and treatment of pulmonary disorders
#1775Method of identifying a compound for the treatment or prevention of obesity
#1776Methods for the early diagnosis of ovarian cancer
#1777SIRNA CAPABLE OF INHIBITING THE EXPRESSION OF AN ONCOGENE INVOLVED IN CERVICAL CANCER
#1778ADFP MODULATORS IN THE TREATMENT OF ACNE, OF SEBORRHOEIC DERMATITIS OR OF HYPERSEBORRHOEA
#1779MicroRNAs and uses thereof
#1780Genetic Variants Predictive of Cancer Risk
#1781Biomarkers for predicting the sensitivity and response of protein kinase CK2-mediated diseases to CK2 Inhibitors
#1782Distinguishing PCA3 messenger RNA species in benign and malignant prostate tissues
#1783HLA alleles associated with adverse drug reactions and methods for detecting such
#1784SCREENING METHOD FOR POLYMORPHIC MARKERS IN HTRA1 GENE IN NEURODEGENERATIVE DISORDERS
#1785TADG-15: an extracellular serine protease overexpossed in carcinomas
#1786Genetic alterations associated with autism and the autistic phenotype and methods of use thereof for the diagnosis and treatment of autism
#1787Gene signature for predicting prognosis of patients with solid tumors
#1788Methods and Compositions for Treating Neuroblastoma
#1789POLYMORPHISM IN THE APO(A) GENE PREDICT RESPONSIVENESS TO ACETYLSALICYLIC ACID TREATMENT
#1790Multi-well platform
#1791Methods and compositions for treating neurodegenerative disorders and Alzheimer's disease and improving normal memory
#1792SCREENING METHOD OF THERAPEUTIC AND DIAGNOSTIC AGENTS FOR TNF-ALPHA-INDUCED DISEASES USING REACTIVE OXYGEN SPECIES MODULATOR 1
#1793METHODS FOR ASSAYING MC1R VARIANTS AND MITOCHONDRIAL MARKERS IN SKIN SAMPLES
#1794DIAGNOSIS AND PROGNOSIS OF IMMUNE DISORDERS USING STAT4 EXPRESSION
#1795Asthma susceptibility loci located at chromosome 1q31 for use in diagnostic and therapeutic methods
#1796Compositions and methods for influencing satiety, lipid metabolism, and fat utilization
#1797Method of inhibiting prostate cancer cell proliferation
#1798ESTROGEN AND ANTI-ESTROGEN MARKER GENES
#1799GUANYLYL CYCLASE C QRT-PCR
#1800DETECTION OF GRANULOSA-CELL TUMORS